Jobs

Passionate about building a future powered by science?
Check out the opportunities in our portfolio companies.
Showing 19 companies
Zymochem
Zymochem
6 jobs
Biotechnology
DeepTech
Manufacturing
11 - 50 employees
Seed

ZymoChem is breakthrough science for a fossil-free future. We accelerate the transition to a real-zero economy by developing bio-based materials for everyday products. Our platform is powered by proprietary carbon conserving (C2) microbes that convert renewable feedstocks into high-value materials while radically minimizing CO2 loss during the production phase.

CytoVale
CytoVale
5 jobs
Biotechnology
Data and Analytics
DeepTech
Health
Software
51 - 200 employees

Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful.

Biotechnology
DeepTech
Design
Health
11 - 50 employees
Series A

A-Alpha Bio provides cell-based tools for quantitative and high-throughput measurements of protein interactions, accelerating target discovery, library screening, and preclinical drug characterization. A-Alpha Bio's product, AlphaSeq, is a revolutionary cell-based platform technology that will fundamentally change the way that protein interactions are measured. A-Alpha Bio is a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck.

Biotechnology
DeepTech
51 - 200 employees
Series C+

Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission to be a catalyst for real-world impact on people and the planet. Modern Meadow’s proprietary Bio-Alloy™ and Bio-F@rm™ technology application platforms harness the unique properties of tuned proteins to sustainably move the world away from petrochemical and animal-derived inputs without compromising on performance. These innovations can drop into any existing infrastructures for immediate scalable adoption in the materials, beauty, and other industries. Our close relationship with development partners and production facilities allows companies partnering with Modern Meadow to feel confident knowing our products are 100% traceable from Lab-to-Brand™.

Biotechnology
DeepTech
Health
11 - 50 employees
Seed

EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.

DeepTech
Energy
Manufacturing
Sustainability
201 - 1000 employees
Series B

We are the carbon transformation(tm) company. We make the world's most critical chemicals, materials and fuels from air with our revolutionary carbon transformation(tm) technology.

Biotechnology
Data and Analytics
DeepTech
Health
Software
1 - 10 employees

Life exists in motion. CellChorus® applies visual AI to evaluate thousands of microscopy experiments in parallel to improve the development and delivery of novel therapies for biopharmaceutical and research customers. The company's Time-lapse Imaging Microscopy in Nanowell Grids (TIMING™) platform provides high-throughput evaluation of how individual cells move, behave, interact and perform.

Biotechnology
DeepTech
Hardware
Manufacturing
Software
51 - 200 employees
Series B

Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics with the goal of fundamentally advancing the life sciences. The Strateos Automation-as-a-Service Platform helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries.

Biotechnology
DeepTech
Health
11 - 50 employees

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of Immusoft’s Immune System Programming (ISP) technology was developed in the Baltimore Lab at the California Institute of Technology (Caltech) and exclusively licensed by Immusoft. The technology instructs a patient’s cells to produce gene-encoded medicines (biologics). Cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients for many years. It was founded in 2009 and is headquartered in Seattle, Washington.

Biotechnology
DeepTech
11 - 50 employees
Seed

Noetik is an AI-native biotechnology company. By harnessing the potential of self-supervised learning and human multimodal data, Noetik aims to discover better precision immunotherapies.

Biotechnology
DeepTech
Health
11 - 50 employees
Seed

Phantom Neuro creates a system that will enable lifelike control of robotic orthopedic technologies, such as prosthetic limbs and exoskeletons.

Biotechnology
DeepTech
Health
1 - 10 employees
Seed

Parallel Bio develops tools that help in the discovery and development of immunotherapies, to eliminate current barriers and create the fastest path to a drug that works. Parallel Bio's platform combines best-in-class human immune organoids with computational methods to generate unprecedented insights into human health and disease.